Ponsegromab Crashes Out in Frailer Heart Failure Patients

by MrezaMk October 3, 2025

written by MrezaMk October 3, 2025 0 comments

(MedPage Today) — MINNEAPOLIS — Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial that was terminated early…

You Might Also Like

Adverse Events Continued After TikTok ‘Benadryl Challenge’
Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say
Mifepristone Is Under Attack Again – With the Same Old Playbook
Who Americans Blame for the Shutdown; CDC Workers Furloughed; Drug Tariffs on Hold

Useful Links

Edtior's Picks

Latest Articles

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

Queue